Sort
326,823 grants matching “clinical trial”
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma
$1,536,934John Peter Wikswo · Vanderbilt University · U01 · FY2020 · TR
Cellular Vaccines for Cancer Therapy
$1,536,897University Of Michigan At Ann Arbor · P01 · FY2005 · CA
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
$1,536,895Robert L. Murphy · Northwestern University · U54 · FY2021 · EB
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
$1,536,833Richard Platt · Harvard Pilgrim Health Care, Inc. · U01 · FY2023 · AI
Comparison of Hemorrhagic & Ischemic Stroke Among Blacks and Whites
$1,536,785Brett M Kissela · University Of Cincinnati · R01 · FY2017 · NS
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias
$1,536,774Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2024 · AG
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP
$1,536,651Steven G. Self · Fred Hutchinson Cancer Research Center · U01 · FY2006 · AI
PATHOBIOLOGY AND GENE TRANSFER IN CARDIOVASCULAR DISEASE
$1,536,624Lawrence Chan · Baylor College Of Medicine · P01 · FY2006 · HL
Improving Cognition via Exercise in Schizophrenia
$1,536,619David Kimhy · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · MH
Anatomic Pathology Residency Program
$1,536,472John Oberholtzer · Division Of Basic Sciences - Nci · ZIE · FY2012 · CA
Prostate Cancer Imaging
$1,536,469Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Frontiers in Congenital Disorders of Glycosylation
$1,536,315Eva Morava-Kozicz · Mayo Clinic Rochester · U54 · FY2021 · NS
Hyperphenylalaninemia Disorders Consortium of the Rare Disease Clinical Research Network
$1,536,308Cary O. Harding · Oregon Health & Science University · U54 · FY2022 · HD
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
$1,536,203C Robert Horsburgh · Boston University Medical Campus · U01 · FY2013 · AI
Drug at the Right Place & Concentration: Optimizing Combination Vaginal Ring PrEP
$1,536,095Betsy C. Herold · Albert Einstein College Of Medicine · U19 · FY2017 · AI
The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care - CCC - Lead Application
$1,536,088Leonard H Epstein · State University Of New York At Buffalo · U01 · FY2016 · HL
Competitive Renewal for Multicenter Uveitis Steroid Treatment (MUST) Trial
$1,535,936Janet T. Holbrook · Johns Hopkins University · U10 · FY2013 · EY
Competitive Renewal for Multicenter Uveitis Steroid Treatment (MUST) Trial
$1,535,936Janet T. Holbrook · Johns Hopkins University · U10 · FY2015 · EY
Competitive Renewal for Multicenter Uveitis Steroid Treatment (MUST) Trial
$1,535,936Janet T. Holbrook · Johns Hopkins University · U10 · FY2014 · EY
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,535,911Gordon R. Bernard · Vanderbilt University · UL1 · FY2010 · RR
Dissemination and Implementation of the SPRINT Study Findings in Underserved Populations
$1,535,823Jiang He · Tulane University Of Louisiana · R01 · FY2018 · HL
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,535,619Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2025 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2022 · AI
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
$1,535,611Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2023 · AI